MedTrace Logo

Safety Follow-Up to HP 802-247-09-015

NCT00900029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2017-08-02

Study results available
· View outcomes & findings →

Summary

This is a 24-week observational follow safety study for Study 802-247-09-015.

Conditions

  • Venous Leg Ulcer
  • Venous Stasis Ulcer

Interventions

BIOLOGICAL

No HP802 Treatment

OTHER

No HP802 Vehicle Treatment

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Hebert B Slade, MD, FAAAAI · Healthpoint

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-10-31
Completion
2012-01-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900029 on ClinicalTrials.gov